Infections in systemic lupus erythematosus;Infections et lupus

Revue du Praticien

Volumn 48, Issue 6, 1998, Pages 637-641

  Le Moing, Vincent ^a   Leport, Catherine ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ARTICLE; CANDIDIASIS; FEVER; HUMAN; INFECTION RISK; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT INDICATION;

ADRENAL CORTEX HORMONES; BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYCOSES; OPPORTUNISTIC INFECTIONS; PARASITIC DISEASES; VIRUS DISEASES;

EID: 6844251584     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Iliopoulos AG, Tsokos GC Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 1996; 25: 318-36.
2. Ginzler EM, Diamond II, Kaplan D, Weiner M, Schlesinger M, Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 37-44.
3. Klemperer P, PollackAD, BaehrG. Pathology of disseminated lupus erythematosus. Arch Pathol 1941; 32: 569-631.
4. th edition, Hahn (eds). Dubois' Lupus Erythematosus, 1996: 903-13.
5. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med 1985; 218: 271-87.
6. Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic pathogens. Medicine 1987; 66: 341-8.
7. Boumpass DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993; 119: 1198-208.
8. Stuck AF, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev infect Dis 1989; 11: 954-63.
9. Staples PJ, Gerding DN, Decker JL, Gordon RS. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974; 17: 1-9.
10. Pohl MA, Lan SP, Berl T and the Lupus Nephritis Collaborative Study Group. Plasmapheresis does not increase the risk for infection In immunosuppressed patients with severe lupus nephritis. Ann intern Med 1991; 114: 924-9.
11. Nguyen TB, Galezowski N, Taksin AL, Carlet J, Lavarde V. Infection à Pneumocystis carinii révélatrice d'un lupus érythémateux disséminé non traité. Rev Med Interne 1995; 16: 146-9.
12. DiNubile MJ, Albornoz MA, Stumacher RJ et al. Pneumococcal softtissue infections: possible association with connective tissue diseases. J Infect Dis 1991; 163: 897-900.
13. Mitchell SR, Nguyen PQ, Katz P. Increased risk of neisserial infections in systemic lupus erythematosus. Semin Arthritis Rheum 1990; 20: 174-84.
14. Feng PH, Tan TH. Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1982; 41: 11-4.
15. Choukroun G, Quint L, Amoura Z et al. Spondylodiscite à Salmonella typhi murium au cours du lupus systémique. Ann Med Interne (Paris) 1988; 139: 446-7.
16. Kahn MF, Peltier AP, Podrabinck N et al. Les infections dans le lupus érythémateux disséminé. Ann Med Interne (Paris) 1977; 128: 31-7.
17. Medina F, Frage A, Lavalle C. Salmonella septic arthritis in systemic lupus erythematosus: the importance of chronic carrier state. J Rheumatol 1989; 16: 203-8.
18. Feinman MC, Friedberg MA, Schwartz JC et al. Central nervous system herpesvirus infection in systemic lupus erythematosus: diagnosis by endoretinal biopsy. J Rheumatol 1993; 20: 1058-61.
19. Kahl LE. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol 1994; 21: 84-6.
20. Livneh A, Coman EA, Cho S, Lipstein-Kresch E. Strongyloides stercoralis hyperinfection mimicking systemic lupus erythematosus flare. Arthritis Rheum 1988; 31: 930-1.
21. Porges AJ, Beattie SL, Ritchlin C et al. Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol 1992; 19: 1191-4.
22. Godeau B, Coutant-Peronne V, Lê Thi Huong Du et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 1994; 21: 246-51.
23. Wechsler B, Lê Thi Huong Du, Vignes B et al. Toxoplasmose et lupus. Revue de la littérature à propos de 4 observations. Ann Med Interne (Paris) 1986; 137: 324-30.
24. Inoue T, Takeda T, Koda S et al. Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis. Rheumatol Int 1986; 6: 69-77.
25. Borg TJ, Horst G, Limburg PC et al. Creactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 1990; 17: 1642-8.
26. Eberhard OK, Haubitz M, Brunkhorst FM et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplamic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250-6.